Medicare Enrolled

Dr. Kruti Shah, MD

Endocrinology · Boardman, OH
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
901 TRAILWOOD DR, Boardman, OH 44512
3307263000
In practice since 2006 (20 years)
NPI: 1891751780 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Shah from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shah? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Shah

Dr. Kruti Shah is an endocrinology specialist in Boardman, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Shah performed 1,423 Medicare services across 781 unique beneficiaries.

Between the years covered by Open Payments, Dr. Shah received a total of $9,442 from 53 pharmaceutical and/or device companies across 567 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Shah is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 22% volume in OH $9,442 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,423
Medicare services
Top 22% in OH for endocrinology
781
Unique beneficiaries
$48
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~71 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Blood glucose test using hand-held instrument
A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels.
520 $3 $20
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
504 $83 $334
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
125 $24 $134
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
73 $125 $448
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
65 $55 $224
Hemoglobin A1c test (diabetes monitoring)
A blood test that measures your average blood sugar levels over the past two to three months.
54 $9 $28
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
53 $100 $509
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
17 $60 $333
New patient office visit, complex (60-74 min) 12 $149 $637
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$9,442
Total received (2018-2024)
Avg $1,349/year across 7 years
Top 25% in OH for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
567
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,306 (98.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$136 (1.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,426
2023
$1,689
2022
$1,419
2021
$1,405
2020
$1,042
2019
$1,544
2018
$917

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$162
GlaxoSmithKline, LLC.
$123
Abbott Laboratories
$115
Medtronic, Inc.
$105
Bayer Healthcare Pharmaceuticals Inc.
$99
Boehringer Ingelheim Pharmaceuticals, Inc.
$91
Xeris Pharmaceuticals, Inc.
$88
Lilly USA, LLC
$86
Corcept Therapeutics
$69
SANOFI-AVENTIS U.S. LLC
$60
Amgen Inc.
$60
ABBVIE INC.
$58
Gilead Sciences, Inc.
$53
Kyowa Kirin, Inc.
$39
CeQur Corporation
$35
PFIZER INC.
$35
Amphastar Pharmaceuticals, Inc.
$31
Insulet Corporation
$25
Chiesi USA, Inc.
$19
BETA BIONICS, INC.
$19
Smith+Nephew, Inc.
$19
Dexcom, Inc.
$19
Avvisto Therapeutics, LLC
$19
Top 3 companies account for 28.0% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$1,379
Lilly USA, LLC
$1,135
Abbott Laboratories
$676
Boehringer Ingelheim Pharmaceuticals, Inc.
$606
Corcept Therapeutics
$558
AstraZeneca Pharmaceuticals LP
$536
Merck Sharp & Dohme Corporation
$427
Amgen Inc.
$389
SANOFI-AVENTIS U.S. LLC
$329
Medtronic, Inc.
$240
Xeris Pharmaceuticals, Inc.
$213
AbbVie Inc.
$208
Novartis Pharmaceuticals Corporation
$181
MannKind Corporation
$178
Amarin Pharma Inc.
$166
Bayer Healthcare Pharmaceuticals Inc.
$154
Janssen Pharmaceuticals, Inc
$142
Insulet Corporation
$134
Gilead Sciences, Inc.
$129
Dexcom, Inc.
$128
GlaxoSmithKline, LLC.
$123
ABBVIE INC.
$115
Alexion Pharmaceuticals, Inc.
$111
Vifor Pharma, Inc.
$108
Otsuka Pharmaceutical Development & Commercialization, Inc.
$100
Ultragenyx Pharmaceutical Inc.
$83
Amneal Pharmaceuticals LLC
$77
Merck Sharp & Dohme LLC
$73
PFIZER INC.
$71
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$69
RECORDATI_RARE_DISEASES_INC.
$59
EUSA Pharma (US) LLC
$59
CeQur Corporation
$51
AbbVie, Inc.
$41
Kyowa Kirin, Inc.
$39
Veryan Medical Incorporated
$31
Amphastar Pharmaceuticals, Inc.
$31
Medtronic MiniMed, Inc.
$30
Boston Scientific Corporation
$30
Amryt Pharma Holdings Ltd
$19
Chiesi USA, Inc.
$19
BETA BIONICS, INC.
$19
Smith+Nephew, Inc.
$19
Avvisto Therapeutics, LLC
$19
DEXCOM, INC.
$19
Integra LifeSciences Corporation
$18
Esperion Therapeutics, Inc.
$17
Endo Pharmaceuticals Inc.
$16
Zealand Pharma US, Inc.
$15
Nestle HealthCare Nutrition Inc.
$15
Radius Health, Inc.
$13
Eisai Inc.
$12
Mylan Specialty L.P.
$11
Top 3 companies account for 33.8% of all-time payments
Associated products mentioned in payments ›
AFREZZA · AREXVY · Aimovig · Androgel · BAQSIMI · BASAGLAR · BYDUREON · Belviq · BioMimics · CYCLOSET · CeQur Simplicity · Crysvita · DEXCOM CGM · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · Dymista · EMGALITY · ENTRESTO · EVENITY · Epclusa · FARXIGA · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre Pro · FreeStyle Libre blood glucose Flash Monitoring System · FreeStyle Lite system · GVOKE HYPOPEN · GVOKE PFS · HUMALOG · HUMULIN · HUMULIN U · INVOKANA · ISTURISA · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQVIO · MINIMED 770G · MINIMED 780G · MOUNJARO · MYCAPSSA · Minimed 670G System · NASCOBAL · NEXLETOL · Omnipod · Ozempic · Prolia · QULIPTA · RECORLEV · RENASYS GO v2 HOME · RYBELSUS · Repatha · Rezum Generator · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · STEGLATRO · STRENSIQ · SURGIMEND · SYNJARDY · SYNTHROID · Saxenda · Strensiq · Sylvant · Synthroid · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tresiba · Tymlos · UBRELVY · UNITHROID · Vascepa · Veltassa · Victoza · WATCHMAN Access System · Wegovy · XIFAXAN · ZEGALOGUE · ZENPEP · iLet Bionic Pancreas
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an endocrinology specialist in Boardman?
Compare endocrinologists in the Boardman area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
5
Per 100K population
2.2
County median income
$55,576
Nearest hospital
HMHP ST ELIZABETH BOARDMAN HEALTH CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Shah is a clinical cardiology specialist, with above-average Medicare volume (top 22% in OH), with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Shah experienced with blood glucose test using hand-held instrument?
Based on Medicare claims data, Dr. Shah performed 520 blood glucose test using hand-held instrument services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shah receive payments from pharmaceutical companies?
Yes. Dr. Shah received a total of $9,442 from 53 companies across 567 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shah's costs compare to other endocrinologists in Boardman?
Dr. Shah's average Medicare payment per service is $48. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shah) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →